The monitoring parameters of pharmacotherapy with a narrow index also warrant consideration (for example, concurrent warfarin may require closer international normalized ratio monitoring)
In short, its the ultimate medication for sustainable weight management
The Zepbound prescribing label includes an identical caution about gastric emptying and oral drug absorption as the Wegovy label
This leads to feelings of satiety, causing reduced food intake and subsequent weight loss
Patient education about expected side effects, their typical duration, and effective management strategies improves treatment satisfaction and persistence, ultimately supporting better clinical outcomes
For instance, while semaglutide GLP-1 can lead to greater weight loss than liraglutide, both medications are known to cause side effects, such as nausea and gastrointestinal discomfort